PRC Clinical
PRC Clinical is a private, founder-led CRO providing customized Phase I-III clinical trial management, monitoring, and eTMF services to small-to-midsize biotech, pharma, and medical device sponsors, with specialized expertise in regenerative medicine, CNS, ophthalmology, and rare diseases.
- Company typePrivate
- Founded2003
- HeadquartersSan Bruno, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What PRC Clinical does
PRC Clinical is a privately held, founder-led Contract Research Organization (CRO) founded in 2003 by Curtis Head (CEO) and Tony Taricco (President) and headquartered in South San Francisco, California. The company delivers customized clinical trial management services to small-to-midsize pharmaceutical, biotechnology, and medical device sponsors, with concentrated therapeutic expertise in regenerative medicine, CNS, ophthalmology, pulmonary, rare/orphan diseases, psychedelics, and pain studies. Its service portfolio spans Phase I through Phase III and is structured around four core offerings — Study Management, Study Monitoring, eTMF & Document Management, and Coordination & Logistics — delivered through Full-Service, Functional Service, or Decentralized-Hybrid engagement models, plus a specialized CRO Transition & Rescue capability for underperforming studies. Named engagements include BioRestorative Therapies (Phase 2 stem cell therapy, up to 99 patients across 15 U.S. centers), RHEACELL (rare disease trial operating in 12 countries and 100 sites via FGK Clinical Research partnership), and an unnamed Israeli stem cell sponsor (Phase II ALS, 48 patients, 3 U.S. sites), alongside a 10-country / 57-site rescue project involving 27,600+ reconstructed documents.
The underlying technology stack combines Veeva Vault eTMF for inspection-ready document management, Salesforce CTMS for metrics and reporting, an internal feasibility database, and AI-assisted tooling for site selection, enrollment prediction, and eTMF document automation. PRC Clinical generates revenue through professional services under multi-year Master Service Agreements, with quote-based, project-by-project pricing tailored to therapeutic area, phase, and scope — no public pricing tiers exist. Its go-to-market is relationship-driven enterprise field sales aimed at biotech, pharma, and medical device sponsors seeking an alternative to large CROs, supplemented by content marketing (blog, case studies), email newsletters, and active presence at industry conferences such as BIO International, Cell & Gene Therapy Summit, and ALS Nexus. The company operates with 11-50 employees, no disclosed external funding, and ownership concentrated with the founding team.
PRC Clinical firmographics
Firmographics- Name
- PRC Clinical
- Legal name
- PRC Clinical
- Website
- https://prcclinical.com
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PRC Clinical is a private, founder-led CRO providing customized Phase I-III clinical trial management, monitoring, and eTMF services to small-to-midsize biotech, pharma, and medical device sponsors, with specialized expertise in regenerative medicine, CNS, ophthalmology, and rare diseases.
- Ownership category
- akta.pro rank
PRC Clinical industry classification
Industry- Product category
- Clinical Research Organization (CRO) Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)
Keywords
Where PRC Clinical is headquartered
LocationHeadquarters
- HQ city
- San Bruno
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PRC Clinical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Clinical Trial Management Services: PRC Clinical generates revenue through providing comprehensive CRO services including study management, monitoring, eTMF document management, and coordination services. Services are delivered under Master Service Agreements with sponsors, typically on a project-by-project basis for clinical trials spanning Phase I through Phase III.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing tailored to trial scope and requirements |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
PRC Clinical product offering
Product offeringCore offering
PRC Clinical is a Contract Research Organization (CRO) that delivers end-to-end clinical trial management services, including Study Management, eTMF & Document Management, Study Monitoring, and Coordination & Logistics for pharmaceutical, biotech, and medical device sponsors. Services span Phase I through Phase III and are delivered via Full-Service, Functional Service, and Decentralized-Hybrid engagement models, with specialization in complex therapeutic areas such as regenerative medicine, CNS, rare/orphan diseases, ophthalmology, pulmonary, and psychedelics research.
Product overview
PRC Clinical is a Contract Research Organization (CRO) providing customized clinical trial management services for pharmaceutical, biotech, and medical device sponsors. Founded in 2003, the company operates as a full-service CRO offering integrated and modular services across clinical operations. Their core service portfolio includes Study Management, eTMF & Document Management, Study Monitoring, and Coordination & Logistics. These services are delivered through multiple models (Full-Service, Functional Service, and Decentralized-Hybrid) and span Phase I through Phase III clinical trials. Additional offerings include Consulting, Protocol Development, Trial Optimization, and specialized CRO Transition & Rescue Services for underperforming studies. The company specializes in therapeutic areas including regenerative medicine, rare & orphan diseases, CNS, ophthalmology, pain trials, psychedelics research, and pulmonary studies. Technology enablers include Salesforce CTMS for trial management, Veeva Vault eTMF for document management, feasibility databases, and AI-powered tools for site selection and enrollment optimization.
Differentiator
Problem solved
Functional benefit
Products and services
- Study Management Hands-on guidance and quality assurance to keep clinical trials on time and on budget, from site selection through day-to-day oversight, with customized management solutions designed to meet milestones with precision. Intended for pharmaceutical, biotech, and medical device sponsors conducting Phase I–III trials.
- eTMF & Document Management Advanced electronic Trial Master File solutions central to clinical trial success, available as a stand-alone service for any study, incorporating AI-powered automation for document management and inspection-ready TMF maintenance. Built on Veeva Vault eTMF; targeted at sponsors needing TMF oversight, audit-ready documentation, and consistent document control across geographies.
- Study Monitoring In-house and regional clinical study monitoring providing consistent oversight and care across the trial process. Targeted at sponsors needing premium-quality site monitoring across Phase I–III trials, including regenerative medicine, CNS, rare disease, and other complex indications.
- Coordination & Logistics Management of vendors, licensure procurement, and laboratory services including specimen management, cell and gene cryo-shipping, and other critical trial logistics. Targeted at sponsors running complex trials (especially regenerative medicine and cell/gene therapy) that require specialized cold-chain and chain-of-identity logistics.
- Phase I Services First-in-Human (FIH) study management including pharmacokinetic (PK) and pharmacodynamic (PD) data collection and Data Safety Monitoring Board (DSMB) meetings. Targeted at sponsors conducting early-phase, first-in-human clinical studies.
- Phase II Services Phase II and Phase IIb trial support with tailored logistical solutions for coordination of data collection tools, instruments, and equipment across 2 to 50+ trial sites. Targeted at sponsors moving from FIH confirmation into expanded efficacy and dose-ranging studies.
- Phase III Services Scalable Phase III trial management providing integrated global partnership with boots-on-the-ground regional support as needed. Targeted at sponsors running pivotal late-phase trials across multiple regions and large site networks.
- CRO Transition & Rescue Services Mid-study transition and rescue engagements for underperforming or at-risk trials, including operational stabilization, TMF recovery, monitoring restoration, and inspection readiness restoration. Targeted at pharma and biotech sponsors whose existing CRO is underperforming or has ceased operations.
- Consulting Expert guidance to help sponsors navigate complex regulatory landscapes and ensure trial success. Targeted at biotech, pharma, and medical device sponsors needing standalone regulatory or operational advisory support.
- Protocol Development Comprehensive protocol creation from synopsis to regulatory input, collaborating closely with sponsors to design protocols that meet regulatory and scientific requirements. Targeted at sponsors needing protocol design support prior to or during trial start-up.
- Trial Optimization Enhancement of protocols and processes to maximize study outcomes through review of trial designs, documents, and workflows for greater efficiency. Targeted at sponsors seeking to improve performance of in-flight or planned trials.
- Regenerative Medicine CRO Services Specialized CRO services for cell, gene, and regenerative medicine studies requiring surgical site readiness, chain-of-identity controls, cold-chain logistics, and compliant execution across autologous and allogeneic programs. Targeted at biotech sponsors in the regenerative medicine space.
- Rare & Orphan Disease CRO Services Expertise in rare and orphan disease trials including challenges with diagnosis, participant enrollment, and patient stress, spanning pediatric, adolescent, and infant trials. Targeted at sponsors developing therapies for rare and orphan indications.
- CNS CRO Services CNS and neurology trial services covering ALS, Alzheimer's, Huntington's, MS, neurodegenerative disorders, pain, and Parkinson's. Targeted at sponsors developing therapies for central nervous system and neurological indications.
- Ophthalmology CRO Services Ophthalmology trial services including achromatopsia, age-related macular degeneration (AMD), dry eye, device trials, and pediatric and adult populations. Targeted at sponsors running trials in ophthalmology and vision-related indications.
- Pain Trial CRO Services Pain studies across diverse modalities including small molecules, biologics, regenerative therapies, and drug-device combinations across acute, chronic, neuropathic, and rare pain conditions. Targeted at sponsors developing pain therapeutics.
- Psychedelics Research CRO Services Psychedelic clinical trial services including psilocybin and ayahuasca research for psychiatric and behavioral disorders. Targeted at sponsors running clinical research in psychedelic-assisted therapies.
- Pulmonary CRO Services Pulmonary clinical research including Idiopathic Pulmonary Fibrosis (IPF), Pulmonary Arterial Hypertension (PAH), and respiratory therapies. Targeted at sponsors developing respiratory and pulmonary therapeutics.
Quantifiable outcome
- Exceeded U.S. enrollment targets for chronic kidney disease study, recruiting significantly more patients than projected and counterbalancing slower recruitment at international sites
- +2 more outcomes
Companies that use PRC Clinical
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
PRC Clinical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
AI capability4 records
Feature4 records
PRC Clinical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- TrialHub (FindMeCure)corePRC Clinical announced a strategic partnership with FindMeCure's TrialHub, a groundbreaking platform for clinical trial strategists. The partnership aims to revolutionize clinical trial planning and enhance the patient experience by leveraging TrialHub's NLP and AI-powered data intelligence platform for optimized site selection and accelerated patient enrollment.
- FGK Clinical ResearchcorePRC Clinical serves as the U.S. operations partner for FGK Clinical Research, a Germany-based CRO contracted by RHEACELL for an international rare disease clinical trial. PRC managed U.S. operations for this global program spanning 12 countries and 100 sites, successfully facilitating first global enrollments.
Scale indicators4 records
Recent moves4 records
Expansion highlights4 records
PRC Clinical competitors and assessment
Company assessmentDirect peers
- Premier Research: Specialty CRO focused on small-to-mid biotech and medical device sponsors with deep therapeutic expertise in rare disease, oncology, and CNS — the closest comparable to PRC's positioning and customer base.
- Medpace: Mid-size, scientifically-led CRO serving small-to-mid biotech sponsors with full-service Phase I–III capabilities. Comparable therapeutic breadth and biotech-centric GTM motion.
- Worldwide Clinical Trials: Mid-size CRO with strong specialty therapeutic expertise (CNS, rare disease, cardiometabolic) and a similar sponsor mix of small-to-mid pharma and biotech — directly overlapping PRC's core verticals.
- Cato Research (Cato SMS): Boutique, science-driven CRO with deep expertise in complex early-phase and rare-disease trials — comparable niche positioning and biotech sponsor base.
- FGK Clinical Research: Germany-based CRO partnering with PRC on the RHEACELL global rare-disease trial; comparable size and Europe-centric operating model with full Phase I–IV services.
Broad incumbents
- IQVIA: Largest global CRO with broad Phase I–IV coverage and a dedicated cell/gene therapy practice area; competes for the same biotech sponsors but at far greater scale and geographic reach.
- Charles River Laboratories: Large CRO with discovery, preclinical, and clinical services — overlapping with PRC on the biotech sponsor base but extending upstream into preclinical and manufacturing.
- ICON plc: Top-tier global CRO with full-service capabilities across all phases and therapeutic areas; competes for biotech and large-pharma sponsors with a much broader portfolio than PRC.
- Syneos Health: Large biopharma solutions and clinical CRO serving biotech through large pharma across all phases — broader portfolio but overlapping biotech sponsor relationships.
Emerging players
- BioAgile (Bionova / Accelsiors): Smaller specialty CRO serving emerging biotech with focus on complex, niche indications — similar boutique scale and biotech-centric model to PRC.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
PRC Clinical social profiles
Digital presencePRC Clinical financial estimates
Financial estimateRevenue estimate
Valuation estimate
PRC Clinical leadership team
Management profileNumber of profiles
Profiles4 records
PRC Clinical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PRC Clinical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PRC Clinical
What does PRC Clinical do?
PRC Clinical is a Contract Research Organization (CRO) that delivers end-to-end clinical trial management services, including Study Management, eTMF & Document Management, Study Monitoring, and Coordination & Logistics for pharmaceutical, biotech, and medical device sponsors. Services span Phase I through Phase III and are delivered via Full-Service, Functional Service, and Decentralized-Hybrid engagement models, with specialization in complex therapeutic areas such as regenerative medicine, CNS, rare/orphan diseases, ophthalmology, pulmonary, and psychedelics research.
Is PRC Clinical a public or private company?
PRC Clinical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PRC Clinical founded?
PRC Clinical was founded in 2003. It employs 11 to 50 people.
Where is PRC Clinical based?
PRC Clinical is headquartered in San Bruno, United States, in the North America region.
How does PRC Clinical make money?
One revenue line is on record: clinical Trial Management Services.
Who are PRC Clinical's main competitors?
Direct peers on record are Premier Research, Medpace, Worldwide Clinical Trials, Cato Research (Cato SMS) and FGK Clinical Research. Broad incumbents are IQVIA, Charles River Laboratories, ICON plc and Syneos Health. BioAgile (Bionova / Accelsiors) is listed as an emerging player.
Does PRC Clinical have an API?
No public API is recorded for PRC Clinical.
What industry is PRC Clinical in?
PRC Clinical's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.